A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease
Study Status
Open to Enrollment
Study Description
This research study is for pregnant women who have either Crohn’s disease or ulcerative colitis.
The study is being conducted to determine whether the rates of birth defects, miscarriages, premature births and other outcomes in women with inflammatory bowel disease (IBD) taking azathioprine/6MP or anti-TNF therapy (Remicade, Humira, Cimzia) are different from those among women with IBD who are taking these medications. Little is known about the effects of these medications on pregnant women and their babies. This information will be valuable in guiding the therapy of women with Crohn’s disease or ulcerative colitis who wish to have children while receiving therapy for their illness.
Study participants will be asked to complete questionnaires when they enter the study, during each trimester of their pregnancy, at delivery and at 4, 9, and 12 months after the birth of their baby.
Disease Status and/or Stage
Pregnant Women with Crohn's Disease or Ulcerative Colitis
Sponsor
Crohn’s Colitis Foundation Clinical Alliance
Key Eligibility
- Pregnant women with Crohn's disease or ulcerative colitis
- Age 18 to 50
Principal Investigator
Contact
- Jill Roberts Center for Inflammatory Bowel Disease
- (212) 746-5077
Healthy Volunteers
As a healthy volunteer in a clinical trial you may make a significant contribution to the discovery of medical knowledge and new treatments that could impact people around the world.
Click here for studies seeking healthy volunteers.
Contact Us
For general inquiries, or if you need assistance finding a study, please contact:
Robert Hagerty
Subject Recruitment Manager
Tel: (646) 962-9340
[email protected]